trial · primary record
OSE2101
Platinum-sensitive Ovarian Cancer
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 185 |
| Primary completion | 2026-12-31 |
| Primary endpoint | Progression free survival (PFS) |
| Registry ID | NCT04713514 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:25.414Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04713514
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.